# Program 1 Phase V - Access, Audit, and Real-Data Boundary Prototype

Phase V creates a non-production prototype for access, audit, and real-data boundary controls.

Phase V does not approve production use. Phase V does not approve real patient data use. Phase V does not authorize PHI/PII ingestion. Phase V does not implement production auth/authz/RBAC. Phase V does not implement production audit logging. Phase V does not create production-grade access enforcement. Phase V does not create production-grade auditability. Phase V does not validate production readiness. Phase V does not authorize go-live.

This phase is docs-only. No backend code, frontend code, migrations, schemas, endpoints, runtime access checks, runtime audit persistence, PHI/PII processing, clinical write workflow, patient messaging, appointment mutation, Task engine, Outcome Evidence, workflow enforcement, approval, clearance, or override behavior is added.

## Continuity

- Phase O designed real patient data governance.
- Phase P designed access control and auditability.
- Phase Q designed validation and safety testing.
- Phase R designed operational readiness.
- Phase S planned control implementation.
- Phase T created ticketing packages.
- Phase U strengthened static governance and non-approval controls.
- Phase V creates a bounded non-production prototype for access, audit, and real-data boundary controls.

## Prototype posture

The Phase V prototype is documentation, model, and checklist material only. It is intended to make future implementation safer by naming actor types, protected categories, prohibited categories, audit event concepts, and real-data boundary decisions before any runtime work begins.

The prototype does not authorize a user, grant access, deny access, persist an audit event, ingest a document, inspect PHI/PII, approve production use, approve real-data use, or close any validation gate.
